AAlta Life Sciences
Alta Life Sciences (rebranded Aliath Bioventures) was a Barcelona-headquartered multistage venture capital platform, part of the AltamarCAM group, investing from seed through commercial growth in biotechnology, medical devices, diagnostics, genomics and digital health. In October 2025 its investment team and funds were fully integrated into Asabys Partners; it no longer operates independently.
SectorsBiotechnology, Medical devices, Diagnostics, Genomics, Digital health
VC MapSeries B
portfolio by sector8
Healthtech & Bio8
Team
G
Guy P. Nohra
Managing General Partner (Alta Life Sciences)
Portfolio companies 9
Open 8 as list → On map →
OOna Therapeutics
entered at Series A, 2020
PPeptomyc
led Series A (estimated), 2026
Ddeepull
led Series A, 2020
MMediktor
led Series A, 2018
IINBRAIN Neuroelectronics
led Series A, 2021
IInbiomotion
led a round, 2021
AAccure Therapeutics
led Series A, 2020
AARTHEx Biotech
per company site
Exited or sunsetted (1)
SSanifit
per company site